NIFTY  9,509.75  0.00%
  SENSEX  30,750.00  0.00%
 CURRENCY  Rs  64.62/$ 72.34/€, 83.25/£
  GOLD  28,644.00  -0.24%
  SILVER  39,770.00  -0.16%
  DAX  12,621.70  -0.17%
  FTSE  7,517.71  0.04%
  CAC  5,337.16  -0.07%
  HANG SENG  25,630.80  0.80%
  NIKKEI  19,813.10  0.36%
  Shanghai Composite  3,107.83  0.71%
  DOW JONES  21,082.90  0.34%
  NASDAQ  6,205.26  0.69%
  S&P 500  2,415.07  0.44%
STOCKS TO WATCH : Vedanta: Aims To Raise Aluminum Output STOCKS TO WATCH : DLF: Aims To Lease 1 Lk Sq Ft Commercial Space In Delhi, Chennai To Start Ups STOCKS TO WATCH : Glenmark: S&P Downgrades Stock's Outlook To Negative From Stable OMCs IN FOCUS : OPEC Agrees To Exclude Nigeria Oil Output Reduction OMCs IN FOCUS : OPEC Agrees To Keep Same Oil Output Targets For Next Nine Months STOCKS TO WATCH : Dr Reddy's: SEZ Unit Completes USFDA Inspection For Second Time STOCKS TO WATCH : Dr Reddy's: USFDA Clears Srikakulum SEZ Unit With 'Zero' Observations STOCKS TO WATCH : Idea Cellular: Gets $215 Mn From EDC STOCKS TO WATCH : MCX: GMEX To Buy 5% Stake In Co STOCKS TO WATCH : Infosys: Strategic Alliances With HP To Accelerate Digital Transformation STOCKS TO WATCH : Tata Tele: Tata DoCoMo Gets CCI Nod To Buy DoCoMo's Stake In Co FERTILISER COS IN FOCUS : Fertiliser Prices Likely To Rise Post GST Rollout GLENMARK PHARMA : Gets USFDA Nod For Generic Of Benicar Tablets CIPLA : U.S. Arm Gets USFDA Approval For Generic Of Zestoretic SUN PHARMA : U.S. Arm Gets USFDA Nod For Generic Of Luxiq Drug

Good Indications Of Demand Outlook: TCS

Video:

Play this video

January 17: Rajesh Gopinathan, CFO & VP, TCS, says, “The first budgeting cycle is being done on a positive note.” Phiroz. A. Vandrevala, Director, TCS, adds, “European companies are excited about digitisation and TCS is well positioned in digitisation business expansion.”